Team:UCL London/Bibliography

From 2011.igem.org

Revision as of 23:53, 21 September 2011 by Kinza.islam92 (Talk | contribs)

Bibliography

Supercoilometer

  1. Straney, R., R. Krah, and R. Menzel, Mutations in the -10 Tataat Sequence of the Gyra Promoter Affect Both Promoter Strength and Sensitivity to DNA Supercoiling. Journal of Bacteriology, 1994. 176(19): p. 5999-6006.
  2. Pemberton, I.K., et al., The G+C-rich discriminator region of the tyrT promoter antagonises the formation of stable preinitiation complexes. Journal of Molecular Biology, 2000. 299(4): p. 859-864.
  3. Lamond, A.I., Supercoiling response of a bacterial tRNA gene. Embo Journal, 1985. 4(2): p. 501-7.
  4. Bowater, R.P., D.R. Chen, and D.M.J. Lilley, Modulation of Tyrt Promoter Activity by Template Supercoiling in-Vivo. Embo Journal, 1994. 13(23): p. 5647-5655.
  5. El Hanafi, D. and L. Bossi, Activation and silencing of leu-500 promoter by transcription-induced DNA supercoiling in the Salmonella chromosome. Molecular Microbiology, 2000. 37(3): p. 583-594.
  6. Bossi, L., et al., The supercoiling sensitivity of a bacterial tRNA promoter parallels its responsiveness to stringent control. Embo Journal, 1998. 17(8): p. 2359-2367.

Manufacturing

  1. http://www.ncbi.nlm.nih.gov/pubmed/19075838

Medicine

  1. http://www.tsim.org.tw/article/A95/abstract/10-afternoon/Rm102/H5N1-3.pdf
  2. WHO, Avian Influenza, [Online] Available at: [Accessed on 16 September 2011)
  3. TED, Seth Berkley: HIV and flu -- the vaccine strategy, [Online] Available at: [Accessed on 14 September 2011)
  4. http://www.medscape.com/viewarticle/487616
  5. Recombinant/ purified protein vaccines, [Online] Available at: [Accessed on 17 September 2011)
  6. Discover Magazine: Vaccine Production Is Horribly Outdated. Here Are 3 Ways to Fix It. [Online] Available at: [Accessed on 17 September 2011)
  7. www.pitt.edu/~super7/32011-33001/32731.ppt
  8. NAE Website - Cell-Culture-Based Vaccine Production: Technological Options, [Online] Available at: [Accessed on 16 September 2011)
  9. David B. Weiner and Ronald C. Kennedy, 1999. Genetic Vaccines. Scientific American, July Issue, pp. 50-57. Cui, Z., 2005. DNA vaccine. Advances in Genetics, Volume 54, pp. 257-289. DNA vaccination: Immune response raised by DNA vaccines [online] Available at: [Accessed on 7 September 2011] David B. Weiner and Ronald C. Kennedy, 1999. How DNA Vaccines Work. [diagram] Same journal.
  10. Wikipedia, Gene gun, [online] Available at: [Accessed on 8 September 2011)
  11. Inovio, Technology: Electroporation-Based DNA Delivery, [online] Available at: [Accessed on 8 September 2011)
  12. Pilling et al., 2002. The Assessment of Local Tolerance, Acute Toxicity, and DNA Biodistribution Following Particle-Mediated Delivery of a DNA Vaccine to Minipigs. Toxicologic Pathology, 30(3), pp 298-305.
  13. Sheets et al., 2006. Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts. Toxicological Sciences, 91(2), pp 610-619.
  14. Sheets et al., 2006. Toxicological Safety Evaluation of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar Despite Differing Plasmid Backbones or Gene-Inserts. Toxicological Sciences, 91(2), pp 620-630
  15. http://www.academicjournals.org/AJB/PDF/pdf2011/7Sep/Roy%20et%20al.pdf
  16. NAE Website - Cell-Culture-Based Vaccine Production: Technological Options, [Online] Available at: [Accessed on 7 September 2011)
  17. Strategies for production of viral vaccines, [Online] Available at: [Accessed on 14 September 2011)
  18. Strategies for production of viral vaccines, [Online] Available at: [Accessed on 14 September 2011)
  19. Strategies for production of viral vaccines, [Online] Available at: [Accessed on 14 September 2011)
  20. U.S. Department of Health and Human Services, CBER and FDA Guidance document. Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications (11/07)
  21. Urthaler et al., 2005. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography. J Gene Med, 11(1): 79-88.
  22. Cupillard et al., 2005. Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats. Vaccine, 23: 1910-1916.
  23. Jensen et al., 1999. Extensive regulation compromises the extent to which DNA gyrase controls supercoiling and growth rate of Escherichia coli. Eur. I. Biochem., 266: 865-877.
  24. Trigueros S and Roca J, 2002. Failure to relax negative supercoiling of DNA is a primary cause of mitotic hyper-recombination in topoisomerase-deficient yeast cells. J Biol Chem., 277(40):37207-11.

Safety

  1. Cupillard, L. et al., 2005. Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccines to protect cats. Vaccine 23: 1910-1916.
  2. Reece, R.J. and Maxwell, A., 1991. DNA Gyrase: Structure and Function. Critical Reviews in Biochemistry and Molecular Biology. 26 (3/4):335-375.
  3. Safety Handbook, 2010/2011. Department of Biochemical Engineering,UCL.
  4. Institute of Child Health Flow Cytometry Core Facility, UCL Biosafety: Important health and safety documents, [online]
    Available from: http://www.ucl.ac.uk/ich/services/lab-services/FCCF/biosafety (Accessed on 25 August 2011)